Interleukin 17 and Its Involvement in Renal Cell Carcinoma
Nowadays, molecular and immunological research is essential for the better understanding of tumor cells pathophysiology. The increasing number of neoplasms has been taken under ‘the molecular magnifying glass’ and, therefore, it is possible to discover complex relationships between the cytophysiolog...
Main Authors: | Michał Jarocki, Julia Karska, Szymon Kowalski, Paweł Kiełb, Łukasz Nowak, Wojciech Krajewski, Jolanta Saczko, Julita Kulbacka, Tomasz Szydełko, Bartosz Małkiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/17/4973 |
Similar Items
-
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
by: Anna Tosi, et al.
Published: (2021-12-01) -
Interleukin 17 in early invasive breast cancer
by: Marina Popović, et al.
Published: (2023-06-01) -
Role of IL-17A and IL-17RA in Prostate Cancer with Lymph Nodes Metastasis: Expression Patterns and Clinical Significance
by: Paweł Kiełb, et al.
Published: (2023-09-01) -
Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment
by: Jakub Karwacki, et al.
Published: (2022-09-01) -
Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives
by: Paweł Kiełb, et al.
Published: (2023-05-01)